BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 36944919)

  • 1. CRISPR-Cas-Driven Single Micromotor (Cas-DSM) Enables Direct Detection of Nucleic Acid Biomarkers at the Single-Molecule Level.
    Chen D; Liang Y; Wang H; Wang H; Su F; Zhang P; Wang S; Liu W; Li Z
    Anal Chem; 2023 Apr; 95(13):5729-5737. PubMed ID: 36944919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas-Powered Amplification-Free Detection of Nucleic Acids: Current State of the Art, Challenges, and Futuristic Perspectives.
    Li Y; Liu Y; Tang X; Qiao J; Kou J; Man S; Zhu L; Ma L
    ACS Sens; 2023 Dec; 8(12):4420-4441. PubMed ID: 37978935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An aM-level sensitive cascade CRISPR-Dx system (ASCas) for rapid detection of RNA without pre-amplification.
    Zhang Y; Chen Y; Zhang Q; Liu Y; Zhang X
    Biosens Bioelectron; 2023 Jun; 230():115248. PubMed ID: 37004283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Y-shaped DNA nanostructures assembled-spherical nucleic acids as target converters to activate CRISPR-Cas12a enabling sensitive ECL biosensing.
    Mei-Ling L; Yi L; Mei-Ling Z; Ying Z; Xiao-Jing H
    Biosens Bioelectron; 2022 Oct; 214():114512. PubMed ID: 35780537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel non-nucleic acid targets detection strategies based on CRISPR/Cas toolboxes: A review.
    Cheng X; Li Y; Kou J; Liao D; Zhang W; Yin L; Man S; Ma L
    Biosens Bioelectron; 2022 Nov; 215():114559. PubMed ID: 35917610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-Generation Diagnostic with CRISPR/Cas: Beyond Nucleic Acid Detection.
    Bhardwaj P; Kant R; Behera SP; Dwivedi GR; Singh R
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplexed Detection Strategies for Biosensors Based on the CRISPR-Cas System.
    Wei C; Lei X; Yu S
    ACS Synth Biol; 2024 Jun; 13(6):1633-1646. PubMed ID: 38860462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating CRISPR-Cas12a with a crRNA-Mediated Catalytic Network for the Development of a Modular and Sensitive Aptasensor.
    Shu X; Zhang D; Li X; Zheng Q; Cai X; Ding S; Yan Y
    ACS Synth Biol; 2022 Aug; 11(8):2829-2836. PubMed ID: 35946354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cas12a/blocker DNA-based multiplex nucleic acid detection system for diagnosis of high-risk human papillomavirus infection.
    Han J; Shin J; Lee ES; Cha BS; Kim S; Jang Y; Kim S; Park KS
    Biosens Bioelectron; 2023 Jul; 232():115323. PubMed ID: 37079992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNase H-Driven crRNA Switch Circuits for Rapid and Sensitive Detection of Various Analytical Targets.
    Li HD; Fang GH; Ye BC; Yin BC
    Anal Chem; 2023 Dec; 95(50):18549-18556. PubMed ID: 38073045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Framework-Hotspot Enhanced Trans Cleavage of CRISPR-Cas12a for Clinical Samples Detection.
    Li F; Li J; Yang W; Yang S; Chen C; Du L; Mei J; Tang Q; Chen X; Yao C; Yang D; Zuo X; Liu P
    Angew Chem Int Ed Engl; 2023 Aug; 62(32):e202305536. PubMed ID: 37278518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Advances in CRISPR sensing and detection technology].
    Wang J; Zhao P; Qin M; Zhao Y; Liu C; Xia X
    Sheng Wu Gong Cheng Xue Bao; 2024 Feb; 40(2):367-377. PubMed ID: 38369827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in amplification-free detection of nucleic acid: CRISPR/Cas system as a powerful tool.
    Qian S; Chen Y; Xu X; Peng C; Wang X; Wu H; Liu Y; Zhong X; Xu J; Wu J
    Anal Biochem; 2022 Apr; 643():114593. PubMed ID: 35157895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FELICX: A robust nucleic acid detection method using flap endonuclease and CRISPR-Cas12.
    Aggarwal N; Liang Y; Foo JL; Ling H; Hwang IY; Chang MW
    Biosens Bioelectron; 2023 Feb; 222():115002. PubMed ID: 36527830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal amplification and output of CRISPR/Cas-based biosensing systems: A review.
    Wang SY; Du YC; Wang DX; Ma JY; Tang AN; Kong DM
    Anal Chim Acta; 2021 Nov; 1185():338882. PubMed ID: 34711321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating CRISPR/Cas within isothermal amplification for point-of-Care Assay of nucleic acid.
    Zhang L; Jiang H; Zhu Z; Liu J; Li B
    Talanta; 2022 Jun; 243():123388. PubMed ID: 35303554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancing sensing technology with CRISPR: From the detection of nucleic acids to a broad range of analytes - A review.
    Xie S; Ji Z; Suo T; Li B; Zhang X
    Anal Chim Acta; 2021 Nov; 1185():338848. PubMed ID: 34711331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A CRISPR-Cas autocatalysis-driven feedback amplification network for supersensitive DNA diagnostics.
    Shi K; Xie S; Tian R; Wang S; Lu Q; Gao D; Lei C; Zhu H; Nie Z
    Sci Adv; 2021 Jan; 7(5):. PubMed ID: 33571114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Versatile CRISPR-Cas12a-Based Biosensing Platform Modulated with Programmable Entropy-Driven Dynamic DNA Networks.
    Wang C; Han C; Du X; Guo W
    Anal Chem; 2021 Sep; 93(38):12881-12888. PubMed ID: 34521192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas based virus detection: Recent advances and perspectives.
    Yin L; Man S; Ye S; Liu G; Ma L
    Biosens Bioelectron; 2021 Dec; 193():113541. PubMed ID: 34418634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.